Krüppel-like factor 2 is an endoprotective transcription factor in diabetic kidney disease
American Journal of Physiology-Cell Physiology · 2024
DOI: 10.1152/ajpcell.00222.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Lulin Min und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Kruppel-Like Transcription Factors, Diabetic Nephropathies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, BLRD VA, HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM).
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is a microvascular complication of diabetes, and glomerular endothelial cell (GEC) dysfunction is a key driver of DKD pathogenesis. Krüppel-like factor 2 (KLF2), a shear stress-induced transcription factor, is among the highly regulated genes in early DKD. In the kidney, KLF2 expression is mostly restricted to endothelial cells, but its expression is also found in immune cell subsets. KLF2 expression is upregulated in response to increased shear stress by the activation of mechanosensory receptors but suppressed by inflammatory cytokines, both of which characterize the early diabetic kidney milieu. KLF2 expression is reduced in progressive DKD and hypertensive nephropathy in humans and mice, likely due to high glucose and inflammatory cytokines such as TNF-α. However, KLF2 expression is increased in glomerular hyperfiltration-induced shear stress without metabolic dysregulation, such as in settings of unilateral nephrectomy. Lower KLF2 expression is associated with CKD progression in patients with unilateral nephrectomy, consistent with its endoprotective role. KLF2 confers endoprotection by inhibition of inflammation, thrombotic activation, and angiogenesis, and thus KLF2 is considered a protective factor for cardiovascular disease (CVD). Based on similar mechanisms, KLF2 also exhibits renoprotection, and its reduced expression in endothelial cells worsens glomerular injury and albuminuria in settings of diabetes or unilateral nephrectomy. Thus KLF2 confers endoprotective effects in both CVD and DKD, and its activators could potentially be developed as a novel class of drugs for cardiorenal protection in diabetic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Medicine/Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
- Renal Section, James J. Peters Veterans Affair Medical Center, Bronx, New York, United States.
ORCID-Profile: Kyung Lee, John Cijiang He
Förderung
- NIDDK NIH HHS
- BLRD VA
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
- U.S. Department of Veterans Affairs
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Min, L., Zhong, F., Gu, L., Lee, K., & He, J. C. (2024). Krüppel-like factor 2 is an endoprotective transcription factor in diabetic kidney disease. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00222.2024
Vancouver
Min L, Zhong F, Gu L, Lee K, He JC. Krüppel-like factor 2 is an endoprotective transcription factor in diabetic kidney disease. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00222.2024
BibTeX
@article{Min2024,
author = {Min, Lulin and Zhong, Fang and Gu, Leyi and Lee, Kyung and He, John Cijiang},
title = {Krüppel-like factor 2 is an endoprotective transcription factor in diabetic kidney disease},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
doi = {10.1152/ajpcell.00222.2024}
}
EUVIMED